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Abstract
Background: IgA deficiency (IgAD) is the most common primary immunodeficiency in Caucasians.
Genetic and environmental factors are suspected to be involved in the development of the disease.
Interleukin-10 (IL-10) is a cytokine with stimulatory activity on immunoglobulin production and it
may be an important regulator in IgAD pathogenesis. The IL-10 gene contains several single
nucleotide polymorphisms (SNPs) and two polymorphic microsatellites located in the 5'-flanking
region. Our aim was to ascertain if any of these polymorphic markers are associated or linked to
IgAD in Spanish patients.
Methods: We genotyped 278 patients with IgAD and 573 ethnically matched controls for the
microsatellites IL-10R and IL-10G and for three single nucleotide polymorphisms at positions -
1082, -819 and -592 in the proximal promoter of the gene. We also included in this study the
parents of 194 patients in order to study the IL-10 haplotypes transmitted and not transmitted to
the affected offspring.
Results: The only allele where a significant difference was observed in the comparison between
IgA deficiency patients and controls was the IL-10G12 allele (OR = 1.58 and p = 0.021). However,
this p value could not withstand a Bonferroni correction. None of the IL-10R or promoter SNP
alleles was found at a different frequency when patients were compared with controls.
Conclusion: Our data do not show any significant difference in IL-10 polymorphism frequencies
between control and IgAD patient samples. Their haplotype distribution among patients and
controls was also equivalent and therefore these microsatellites and SNPs do not seem to influence
IgAD susceptibility.
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Background
IgA deficiency (IgAD) is the most common primary
immunodeficiency in Caucasians and is sometimes asso-
ciated with deficiency of IgG2, IgG3, IgG4 and IgE [1].
Genetic studies indicate that IgAD may have an inherited
component and the disease is associated with certain sus-
ceptibility genes located in the major histocompatibility
complex region [2,3]. Celiac disease and selective IgA defi-
ciency are frequently associated, and share a similar
genetic background [4,5]. Environmental factors also play
a role in the occurrence of IgAD. The most usual conse-
quence of this disease is an increased susceptibility to
infection [6].
Although the basic immunologic defect that underlies
IgAD is unknown, a number of in vitro immunological
alterations have been identified: arrest in the B cell differ-
entiation pathway [7], and a decrease in T helper lym-
phocyte function [8,9].
IL-10 is a regulatory cytokine that has several functions; it
is a potent stimulator of NK cells [10] and has stimulatory
effects in B-cell proliferation but due to what has been
termed "the dual role" of IL-10, it has also inhibitory
effects and suppresses the proinflammatory functions of
antigen-presenting cells (APCs) by antagonizing expres-
sion of costimulatory molecules, the release of proinflam-
matory cytokines and, in general, APC maturation [11-
14]. In addition to inhibiting APC maturation, IL-10 pro-
longs their capability for antigen uptake while simultane-
ously postponing their migration to draining lymph
nodes. Finally, the IL-10 knockout mouse develops
chronic enterocolitis [15], highlighting its important role
as modulator of mucosal immunity.
Peripheral blood mononuclear cells (PBMC) from IgAD
patients cultured in the CD40/SAC (Staphylococcus aureus
Cowan) system produced IgM and IgG, but not IgA. The
addition of IL-10 to the cultures enhanced the production
of IgM and IgG and most strikingly induced the produc-
tion of high amounts of IgA. Thus, IL-10 can remove the
block in B cell differentiation and allows B cells from
IgAD patients to differentiate into IgA secreting cells [16].
The IL-10 gene is located on the long arm of human chro-
mosome 1 and its proximal promoter contains three sin-
gle nucleotide polymorphisms (SNPs) at positions -1082
(A/G), -819 (T/C) and -592 (C/A) (17–20). Only three
haplotypes have been described in Caucasian popula-
tions: ATA, ACC and GCC. The production level of this
cytokine is mainly determined by the mRNA synthesis
rate, which in turn depends on these promoter polymor-
phisms [17]. The 5'-flanking region also contains two mic-
rosatellites: IL-10G and IL-10R [18,19]. The haplotypes
formed by both microsatellites also correlate with
cytokine production, presumably due to the linkage dise-
quilibrium between promoter and microsatellite alleles
forming extended haplotypes [20,21].
There is only a previous study analyzing polymorphisms
of IL-10 polymorphisms in IgA deficiency [22], but the
small sample size did not allow reaching definite conclu-
sions. The present study is aimed at performing a compre-
hensive association analysis of IL-10R and IL-10G
microsatellites and IL-10 proximal promoter SNPs in a
large Spanish sample of IgA deficiency patients. We found
no evidence of association of IL-10 polymorphisms to
IgAD in the Spanish population in our study.
Methods
The study group consisted of 278 Caucasian Spanish
patients (45% female) with IgA deficiency. They were
diagnosed by serology criteria (serum IgA level below 0.05
g/l). The samples were recruited from a single centre (La
Paz Hospital, Madrid, Spain) and most of them have been
included in previous studies from our group. Informed
consent was obtained from all the participants. This study
was approved by the Ethics Committee of the Hospital
Clínico San Carlos, and it is in compliance with the Hel-
sinki declaration. The patients can be distributed in differ-
ent groups, according to their clinical symptomatology:
allergy (16%), autoimmune disease (17%), celiac disease
(6%), infectious diseases (13%), psoriasis (4%), other
(44%) or according to the presence of auto-antibodies:
anti IgA antibodies (16%), antinuclear antibodies (11%),
anticardiolipins (3%), microsomal antibodies (3%) and
no antibodies (67%). We could also obtain progenitor
samples of 194 patients (usually trios father-mother-
patient). A group of 573 healthy white, unrelated subjects
(50.8% women) from the Madrid region (mainly Hospi-
tal employees and blood donors) was selected as controls.
Many of the patient and familiy samples have been
included in previous studies of our group in the field of
IgAD genetics [23-25]
IL-10G and IL-10R microsatellites were amplified using
primers and conditions previously described [20]. Sam-
ples were subsequently denatured and run on an ABI
Prism 3100 automatic sequencer (Applied Biosystems,
Foster City, Calif.). Each sample included an internal size
standard (HD400 ROX; Applied Biosystems) to achieve a
highly consistent measure. The results were analyzed
using GeneMapper v3.0 (Applied Biosystems).
There are only three IL-10 promoter haplotypes (GGC,
ATA, ACC) described [21,26,27] in our population. That
is why we have only analyzed the first (-1082) and the
third (-592) position in the IgAD patients and we then
obtained the second position (-819) by a simple deduc-
tion. The SNP study has been performed using TaqManBMC Medical Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2350/7/56
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probes (C___1747360_10 for -1082 and
C___1747363_10 for -592) under conditions recom-
mended by the manufacturer. The samples were read by
two observers and some samples with known results were
included in the analysis as quality controls. Healthy con-
trols were typed (all three positions) as described else-
where [26]. Concordance between the two techniques was
total.
The frequencies of each marker allele in patients and con-
trols were compared by a standard Chi-Square test. The
comparisons between haplotypes transmitted and not
transmitted were also done by this method. For each
locus, a Bonferroni correction was applied. Only alleles
found at a frequency higher than 3% were taken into
account for correction purposes. A result was considered
significant if Pc < 0.05. The present study has a statistical
power of 80% to detect an association with a relative risk
of 1.5 for an allele with a phenotypic frequency of 0.2.
Results
Table 1 shows the results from the IL-10R and IL-10G mic-
rosatellite analysis. The alleles found at a higher frequency
were IL-10R2 for IL-10R, and IL-10G9 and IL-10G13 for
IL-10G, as described in other Caucasian populations. The
IL-10R1, IL-10G1-G6 and IL-10G16-G17 alleles were
extremely rare, also in keeping with previous reports.
In the comparison between IgA deficiency patients and
controls the only significantly different value observed
was the frequency of IL-10G12 allele, higher in patients,
(OR = 1.58, p = 0.021). However, this p value could not
withstand a Bonferroni correction. None of the IL-10R
alleles was found at a different frequency in the group of
patients when compared with controls.
Table 2 displays the results observed in IL-10 promoter
polymorphisms. The IL-10 promoter haplotype with
higher frequency, both in patients and in controls, was
G(C)C. We did not observe any significant difference
between patients and controls when promoter frequen-
cies were compared.
Table 3 shows the extended haplotypes comprising IL10R,
IL10G microsatellites and IL-10 gene promoter SNPs
more frequently found in families, sorted in transmitted
to the patients and not transmitted to them. The extended
haplotype more frequent was IL10R2-IL10G9-A(T)A.
Haplotypes extremely rare in our study are included under
the "Others" heading. As it can be observed, there are
more transmitted haplotypes in total (388) than non-
transmitted (332). This is because in absence of one pro-
genitor we could not obtain the haplotype non-transmit-
ted by that progenitor, unless an additional family
member was available. We can observe a greater propor-
tion of IL10R2-IL10G13-G(C)C haplotype transmitted
than no transmitted (OR = 2.0, p = 0.024), but again the
p value failed to reach a statistically significant level after
Bonferroni correction.
Due to the well-known association of IgAD with HLA hap-
lotypes (marked by DR1 or DRB1*0102, DR3 and DR7 as
risk factors, and DR2-DQ6 as a protection haplotype), we
performed HLA-stratified analyses of the IL-10 polymor-
phisms, but no interaction of IL-10 alleles with any pre-
disposition-related HLA allele or haplotype was found
(data not shown).
Discussion
In this study we have undertaken an association analysis
of IL-10 polymorphisms (IL-10R and IL-10G microsatel-
lites and promoter SNPs) in a large sample of Spanish
patients with IgA deficiency. Our data do not show any
significant difference between control and patient sam-
ples. The haplotypic distribution among patients and con-
trols was equivalent and consequently these
microsatellites and SNPs do not seem to affect IgA defi-
ciency susceptibility per se.
A possible caveat that has always to be considered when a
negative result is reached is that the sample size may not
be large enough and that in consequence we can not see a
possible difference between cases and controls. It is our
Table 1: Phenotypic frequencies of IL-10R and IL-10G 
microsatellites in patients with IgA deficiency (n = 278) and 
controls (n = 573)
IL-10R Patients % Controls %
2 266 96 552 96
39 7 3 5 1 9 8 3 4
4 11 4 19 3.3
IL-10G Patients % Controls %
71 3 5 1 6 3
81 2 4 3 4 6
9 150 54 305 53
10 37 13 75 13
11 66 24 140 24
12 47 17 63 11
13 109 39 262 46
14 44 16 81 14
15 7 3 18 3
Table 2: Phenotypic frequencies of IL-10 promoter haplotypes in 
patients with IgA deficiency (n = 271) and controls (n = 529)
Allele Patients % Controls %
ATA 121 45 235 44
ACC 150 55 287 54
GCC 179 66 332 63BMC Medical Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2350/7/56
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belief that the present study has a reasonable statistical
power (80% power to detect a relative risk of 1.5 with an
allele frequency of 0.1) so we can confidently conclude
that if there is in fact an effect, it should be a rather small
one because our sample is powered enough to detect any
clinically relevant effect. Another reason that could
explain our negative results is that the polymorphisms we
have studied do not have functional relevance, or are not
in linkage disequilibrium with relevant polymorphisms
located elsewhere in the IL-10 gene. However there are
functional studies implicating the position -1082 of the
IL-10 promoter and IL-10R/IL-10G microsatellite haplo-
types [20] in the production in vitro of IL-10. Moreover,
the high degree of linkage disequilibrium and the pres-
ence of extended haplotypes [21] make our choice of
genetic markers useful to incorporate most of the genetic
information present at the IL-10 locus.
As we know, IL-10 has a dual role both as inhibitory and
stimulatory component of the immune responses. There
are not references in the bibliography reporting that an
alteration of IL-10 levels could eventually cause an immu-
nodeficiency. On the contrary, there have been many
studies that find genetic associations of the IL-10 poly-
morphisms with inflammatory diseases like rheumatoid
arthritis, type 1 diabetes, systemic lupus erythematosus or
inflammatory bowel diseases [19,26-30]. Therefore the
evidence suggests that IL-10 deficiency or alteration could
be more important as an etiologic factor in autoimmune
diseases than in immunodeficiencies. This conclusion is
supported by studies with IL-10 knock-out mice, which
develop a chronic enterocolitis. The administration of IL-
10 to these mice ameliorates the symptoms of the disease
[15]. Administration of recombinant human IL-10 to col-
itis patients is being evaluated as a therapeutic option in
colitis patients. It may be speculated that the role of IL-10
as stimulatory factor is redundant with that of other
cytokines (e.g. IL-6), and therefore a defect in one of its
positive effects is not clinically detectable. Only inhibitory
functions of IL-10 might be non-redundant.
Therefore we can conclude that, in terms of sample size,
genetic markers included, and haplotype analysis, our
work greatly expands previous bibliography about the
effect of IL-10 polymorphisms on IgAD. It would be really
interesting in the future to analyze further the IL-10 locus
and its possible interactions with other loci  coding for
other molecules involved in B cell maturation and final
differentiation to plasma cells, like genes coding for IL-10
receptor chains or the gene recently described as associ-
ated with IgAD and common variable immunodeficiency,
TACI [31,32].
Conclusion
Our data do not show any significant difference in IL-10
polymorphism frequencies between control and IgAD
patient samples. Their haplotype distribution among
patients and controls was also equivalent and therefore
these microsatellites and SNPs do not seem to influence
IgAD susceptibility.
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